相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lower circulating preptin levels in male patients with osteoporosis are correlated with bone mineral density and bone formation
Ning Li et al.
BMC MUSCULOSKELETAL DISORDERS (2013)
Concentrations of preptin, salusins and hepcidins in plasma and milk of lactating women with or without gestational diabetes mellitus
Suleyman Aydin et al.
PEPTIDES (2013)
Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight
Cathrine Hoyo et al.
CANCER CAUSES & CONTROL (2012)
Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro
V. D'Esposito et al.
DIABETOLOGIA (2012)
The production and regulation of IGF and IGFBPs in human adipose tissue cultures
Mette Faurholdt Gude et al.
GROWTH HORMONE & IGF RESEARCH (2012)
Metformin in cancer: translational challenges
Ryan J. O. Dowling et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Insulin-like Growth Factor 2/H19 Methylation at Birth and Risk of Overweight and Obesity in Children
Ellen Perkins et al.
JOURNAL OF PEDIATRICS (2012)
Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells
Stephanie M. Piecewicz et al.
PLOS ONE (2012)
The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level
Zhiqin Bu et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2012)
Genetic variants in central metabolic genes influence some but not all relations of inflammatory markers in a collective with polycystic ovary syndrome
Birgit Knebel et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2012)
An appraisal of serum preptin levels in PCOS
Onder Celik et al.
FERTILITY AND STERILITY (2011)
Serum and follicular fluid levels of IGF-II, IGF-binding protein-4 and pregnancy-associated plasma protein-A in controlled ovarian hyperstimulation cycle between polycystic ovarian syndrome (PCOS) and non-PCOS women
Gang Zhong et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
The Link between the Metabolic Syndrome and Cancer
Sandra Braun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Differential effects of IGF-I, IGF-II and insulin in human preadipocytes and adipocytes - Role of insulin and IGF-I receptors
Karolina Back et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Research Resource: New and Diverse Substrates for the Insulin Receptor Isoform A Revealed by Quantitative Proteomics After Stimulation With IGF-II or Insulin
Alaide Morcavallo et al.
MOLECULAR ENDOCRINOLOGY (2011)
Periconceptional nutrition and the early programming of a life of obesity or adversity
S. Zhang et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2011)
Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3
Jay H. Fowke et al.
ENDOCRINE-RELATED CANCER (2010)
Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition
Damien P. Belobrajdic et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes
Nilani Jeyaratnaganthan et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity
S. Kalla Singh et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Several obesity- and nutrient-related gene polymorphisms but not FTO and UCP variants modulate postabsorptive resting energy expenditure and fat-induced thermogenesis in obese individuals: the NUGENOB Study
G. H. Goossens et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
High sensitivity of β-cell replication to the inhibitory effects of interleukin-1β: modulation by adenoviral overexpression of IGF2 in rat islets
Elisabet Estil-les et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women
David P. Rose et al.
ENDOCRINE REVIEWS (2007)
Study of association between common variation in the insulin-like growth factor 2 gene and indices of obesity and body size in middle-aged men and women
Barbara Heude et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo
J. Cornish et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II
Elizabeth M. Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with Type 2 diabetes
AH Heald et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Pro- and mature IGF-II during diet-induced weight loss in obese subjects
U Espelund et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues:: modulation by aging and differentiation in rat adipose tissue
R Serrano et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2005)
Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome
A Sparago et al.
NATURE GENETICS (2004)
Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity
JL San Millán et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
A Juul
GROWTH HORMONE & IGF RESEARCH (2003)
Low circulating IGF-II concentrations predict weight gain and obesity in humans
MJS Sandhu et al.
DIABETES (2003)
IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte
KW Siddals et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet β-cells and enhances insulin secretion
CM Buchanan et al.
BIOCHEMICAL JOURNAL (2001)
Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy -: Evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
J Spranger et al.
HORMONE AND METABOLIC RESEARCH (2001)
Insulin-lowering drugs in polycystic ovary syndrome
MJ Iuorno et al.
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2001)
IGF-II promotes mesoderm formation
OG Morali et al.
DEVELOPMENTAL BIOLOGY (2000)
Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy
J Spranger et al.
HORMONE AND METABOLIC RESEARCH (2000)
Transgenic mice overexpressing insulin-like growth factor-II in β cells develop type 2 diabetes
JC Devedjian et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
